The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge

doi:10.1038/s41590-020-0779-1

. 2020 Oct;21(10):1146-1151.

doi: 10.1038/s41590-020-0779-1.

The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge

Maja Buszko¹, Jung-Hyun Park², Daniela Verthelyi³, Ranjan Sen⁴, Howard A Young⁵, Amy S Rosenberg⁶

Affiliations

¹ Cellular Immunology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
² Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
³ Laboratory of Innate Immunity, Division of Biotechnology Review and Research-III, Office of Biotechnology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
⁴ Laboratory of Molecular Biology and Immunology, National Institute on Aging, Baltimore, MD, USA.
⁵ Laboratory of Cancer Immunometabolism, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD, USA.
⁶ Laboratory of Immunology, Division of Biotechnology Review and Research-III, Office of Biotechnology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA. amy.rosenberg@fda.hhs.gov.

PMID: 32855555
DOI: 10.1038/s41590-020-0779-1

The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge

Maja Buszko et al. Nat Immunol. 2020 Oct.

. 2020 Oct;21(10):1146-1151.

doi: 10.1038/s41590-020-0779-1.

Authors

Maja Buszko¹, Jung-Hyun Park², Daniela Verthelyi³, Ranjan Sen⁴, Howard A Young⁵, Amy S Rosenberg⁶

Affiliations

¹ Cellular Immunology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
² Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
³ Laboratory of Innate Immunity, Division of Biotechnology Review and Research-III, Office of Biotechnology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
⁴ Laboratory of Molecular Biology and Immunology, National Institute on Aging, Baltimore, MD, USA.
⁵ Laboratory of Cancer Immunometabolism, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD, USA.
⁶ Laboratory of Immunology, Division of Biotechnology Review and Research-III, Office of Biotechnology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA. amy.rosenberg@fda.hhs.gov.

PMID: 32855555
DOI: 10.1038/s41590-020-0779-1

No abstract available

PubMed Disclaimer

Cited by

Clinical features of COVID-19 infection in patients with myasthenia gravis: a real-world retrospective study.
Li HN, Xu XN, Qin YH, Liu R, Guo WY, Huang XY, Fan ML, Zhang LJ, Qi Y, Zhang C, Yang L, Shi FD, Yang CS. Li HN, et al. Front Public Health. 2024 Aug 27;12:1421211. doi: 10.3389/fpubh.2024.1421211. eCollection 2024. Front Public Health. 2024. PMID: 39257951 Free PMC article.
Porcine cis-acting lnc-CAST positively regulates CXCL8 expression through histone H3K27ac.
Gao J, Yu H, Pan Y, Wang X, Zhang H, Xu Y, Ma W, Zhang W, Fu L, Wang Y. Gao J, et al. Vet Res. 2024 May 7;55(1):56. doi: 10.1186/s13567-024-01296-9. Vet Res. 2024. PMID: 38715098 Free PMC article.
Potential marker subset of blood-circulating cytokines on hematopoietic progenitor-to-Th1 pathway in COVID-19.
Takashima Y, Inaba T, Matsuyama T, Yoshii K, Tanaka M, Matsumoto K, Sudo K, Tokuda Y, Omi N, Nakano M, Nakaya T, Fujita N, Sotozono C, Sawa T, Tashiro K, Ohta B. Takashima Y, et al. Front Med (Lausanne). 2024 Feb 27;11:1319980. doi: 10.3389/fmed.2024.1319980. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38476443 Free PMC article.
Emerging Role of Kinin B1 Receptor in Persistent Neuroinflammation and Neuropsychiatric Symptoms in Mice Following Recovery from SARS-CoV-2 Infection.
Sriramula S, Theobald D, Parekh RU, Akula SM, O'Rourke DP, Eells JB. Sriramula S, et al. Cells. 2023 Aug 19;12(16):2107. doi: 10.3390/cells12162107. Cells. 2023. PMID: 37626917 Free PMC article.
Targeting Inflammasome Activation in Viral Infection: A Therapeutic Solution?
Deng CH, Li TQ, Zhang W, Zhao Q, Wang Y. Deng CH, et al. Viruses. 2023 Jun 27;15(7):1451. doi: 10.3390/v15071451. Viruses. 2023. PMID: 37515138 Free PMC article. Review.

See all "Cited by" articles

References

1. Wrapp, D. et al. Science 367, 1260–1263 (2020). - DOI
1. Del Valle, D. M. et al. Nat. Med. https://doi.org/10.1038/s41591-020-1051-9 (2020).
1. Diao, B. et al. Front. Immunol. 11, 827 (2020). - DOI
1. van de Veerdonk, F. L. et al. Elife https://doi.org/10.7554/eLife.57555 (2020).
1. Ni, L. et al. Immunity 52, 971–977.e3 (2020). - DOI

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group

[1] Wrapp, D. et al. Science 367, 1260–1263 (2020). - DOI

[2] Wrapp, D. et al. Science 367, 1260–1263 (2020). - DOI

[3] Del Valle, D. M. et al. Nat. Med. https://doi.org/10.1038/s41591-020-1051-9 (2020).

[4] Del Valle, D. M. et al. Nat. Med. https://doi.org/10.1038/s41591-020-1051-9 (2020).

[5] Diao, B. et al. Front. Immunol. 11, 827 (2020). - DOI

[6] Diao, B. et al. Front. Immunol. 11, 827 (2020). - DOI

[7] van de Veerdonk, F. L. et al. Elife https://doi.org/10.7554/eLife.57555 (2020).

[8] van de Veerdonk, F. L. et al. Elife https://doi.org/10.7554/eLife.57555 (2020).

[9] Ni, L. et al. Immunity 52, 971–977.e3 (2020). - DOI

[10] Ni, L. et al. Immunity 52, 971–977.e3 (2020). - DOI

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge

Affiliations

The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge

Authors

Affiliations

Similar articles

Cited by

References

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Similar articles

Cited by

References

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources